<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The last decade has seen a transformation in the endoscopic management of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> associated <z:mpath ids='MPATH_589'>dysplasia</z:mpath> from simple surveillance to therapeutic tissue eradication </plain></SENT>
<SENT sid="1" pm="."><plain>The combined approach using endoscopic mucosal resection and ablative techniques has proven to be safe and effective </plain></SENT>
<SENT sid="2" pm="."><plain>This strategy provides a more cost-effective and safer alternative to esophagectomy for patient with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Despite its safety and efficacy, many questions remain regarding durability, complications, and risk-stratification of patients for endoscopic therapy </plain></SENT>
<SENT sid="4" pm="."><plain>However, endoscopic therapy provides a safe and effective weapon against the rising incidence of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>